Developer docs
API playgroundTry for free, no card

Search company profiles

Central Pharmacy Logistics Australia

Full company profile

uuid002vxmp

Namestring
Central Pharmacy Logistics Australia
Legal namestring
Central Pharmacy Logistics Australia
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Central Pharmacy Logistics Australia (CPL) is an Australian privately-held clinical trial supply chain specialist that delivers and collects Investigational Products (IP) directly to and from patients' homes through its Direct-to-Patient (DTP) and Direct-From-Patient (DFP) service models. The company is positioned as the 'Australian-first' decentralized clinical trial (DCT) distributor, targeting the country's rural and remote patient population — cited as close to 30% of Australians — that traditional site-based trials underserve. Customers are enterprise buyers: pharmaceutical companies, Contract Research Organisations (CROs), clinical trial sponsors, and academic researchers seeking improved recruitment and retention. Secondary channel partners include in-home care providers for administration and nursing coordination.

The underlying technology is operational rather than digital: a TGA-licensed, GMP-compliant depot in Coburg North, Melbourne (ten minutes from the international airport) with temperature monitoring, backup generator, 24/7 CCTV surveillance, and security checkpoints, staffed by GMP/GCP trained pharmacists accountable for dispensing. Distribution is executed by trained premium couriers to patient homes wherever located in Australia, with end-to-end project management from dispensing through to administration. The company describes itself as a supply-chain service rather than a software platform; no API, app, or AI/ML capability is disclosed.

CPL operates on a professional-services revenue model with quote-based pricing (not publicly disclosed) and a sales-led go-to-market using direct outreach, a website contact form, and organic LinkedIn and Twitter presence. The founder-CEO Rima Darwiche, a registered pharmacist with two decades of clinical research experience, leads the firm. The company is independently owned with no parent company, no disclosed funding rounds, and a single domestic operating geography, making it a small specialist contractor in a category with strong tailwinds from the global shift toward decentralized trials.

Short descriptiontext

Central Pharmacy Logistics Australia (CPL) is a privately-held Australian clinical trial supply chain specialist that delivers and collects Investigational Products directly to and from patients' homes via its TGA-licensed Melbourne depot, serving pharmaceutical sponsors, CROs, and researchers running decentralized clinical trials across Australia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial logistics, direct-to-patient supply, investigational product distribution, decentralised clinical trials, pharmacy depot services
Industry3 codes
PRIMARYHLAGAMAC
Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLAIACAD
Pharmaceutical & Life Sciences Warehousing (GDP-Compliant)
Transportation & Logistics/Third-Party & Fourth-Party Logistics (3PL/4PL) / Contract Logistics/Warehousing Operations & Contract Storage (Dedicated/Shared)
SECONDARYTLAAAIAA
Clinical Specimen & Lab Diagnostics Courier (Blood, Tissue, Pathology)
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Supply Chain Services
TypeProfessional Services
Description

Professional services for clinical drug trial distribution including storage, dispensing, and Direct-to-Patient delivery of Investigational Products (IP). Revenue is generated through service fees for managing the complete supply chain from depot to patient homes.

cplaustralia.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Central Pharmacy Logistics Australia provides Direct-to-Patient (DTP) delivery and Direct-From-Patient (DFP) collection of investigational products for clinical drug trials across Australia. Services are anchored at a TGA-licensed, GMP-compliant Melbourne depot operated by GMP/GCP-trained pharmacists, supported by premium couriers who deliver investigational products to and from patients' homes, enabling decentralised clinical trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Close to 30% of Australian population in rural/remote areas can participate in clinical trials
Product overview1 text field

CPL offers a unified clinical trial supply chain platform centered on its Direct-to-Patient (DTP) and Direct-From-Patient (DFP) models. The DTP service enables investigational products to be delivered and administered at patients' homes, while the DFP service handles collection and return of products and samples. These services are supported by CPL's Melbourne-based depot, which provides temperature-controlled storage, GMP/GCP compliant dispensing by licensed pharmacists, and secure distribution through trained premium couriers.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Now part of UPS Healthcare, Marken is a global clinical trial logistics specialist offering Direct-to-Patient and Direct-From-Patient services, biologic specimen transport, and depot operations — a direct global counterpart to CPL's Australian DTP/DFP offering.

TypeDirect peer
Description

Biocair specializes in temperature-controlled life sciences logistics including clinical trial IMP distribution, biological sample transport, and decentralized trial support — a close functional analogue to CPL's GMP depot and DTP model.

TypeEmerging player
Description

Cryoport provides temperature-controlled supply chain solutions for life sciences, including clinical trial logistics for cell and gene therapies. Its emerging focus on complex biologic trial logistics overlaps with parts of CPL's GMP/GCP-monitored DTP offering.

TypeDirect peer
Description

Owned by Cencora, World Courier operates in over 50 countries with clinical trial supply chain, GMP-compliant storage, and DTP/DFP capabilities — overlapping directly with CPL's service portfolio at a materially larger scale.

TypeBroad incumbent
Description

Almac provides end-to-end clinical trial supply, including clinical trial packaging, distribution, and clinical technologies. Its global clinical supply chain services sit alongside CPL's specialist depot/DTP offering but at significantly broader scale.

TypeBroad incumbent
Description

DHL's Life Sciences division provides clinical trial logistics, cold-chain warehousing, and global distribution for pharmaceutical and biotech customers. As a broad incumbent, it competes with CPL on enterprise clinical trial contracts in Australia and the broader APAC region.

TypeEmerging player
Description

Clinipace / dMed Global is a mid-sized CRO with embedded clinical supply and decentralized trial capabilities, offering overlapping support to sponsors running decentralized trials in Australia.

8Fisher Clinical Services (Thermo Fisher Scientific)
TypeBroad incumbent
Description

Part of Thermo Fisher, Fisher Clinical Services offers clinical trial packaging, labeling, storage, and global distribution including direct-to-patient logistics — a broader-portfolio incumbent comparable to CPL's clinical supply chain services.

TypeDirect peer
Description

Movianto (part of Walden) operates as a specialty pharmaceutical logistics provider offering warehousing, distribution, and clinical trial supply across Europe, with capabilities that closely mirror CPL's TGA-licensed depot and DTP focus.

10Yourway Transport
TypeDirect peer
Description

Yourway is a niche clinical trial logistics provider offering bio-pharmaceutical courier, clinical storage, and direct-to-patient services; functionally comparable to CPL though operating primarily in the Americas and Europe.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Central Pharmacy Logistics Australia

Central Pharmacy Logistics Australia (CPL) is a privately-held Australian clinical trial supply chain specialist that delivers and collects Investigational Products directly to and from patients' homes via its TGA-licensed Melbourne depot, serving pharmaceutical sponsors, CROs, and researchers running decentralized clinical trials across Australia.

What Central Pharmacy Logistics Australia does

Central Pharmacy Logistics Australia (CPL) is an Australian privately-held clinical trial supply chain specialist that delivers and collects Investigational Products (IP) directly to and from patients' homes through its Direct-to-Patient (DTP) and Direct-From-Patient (DFP) service models. The company is positioned as the 'Australian-first' decentralized clinical trial (DCT) distributor, targeting the country's rural and remote patient population — cited as close to 30% of Australians — that traditional site-based trials underserve. Customers are enterprise buyers: pharmaceutical companies, Contract Research Organisations (CROs), clinical trial sponsors, and academic researchers seeking improved recruitment and retention. Secondary channel partners include in-home care providers for administration and nursing coordination.

The underlying technology is operational rather than digital: a TGA-licensed, GMP-compliant depot in Coburg North, Melbourne (ten minutes from the international airport) with temperature monitoring, backup generator, 24/7 CCTV surveillance, and security checkpoints, staffed by GMP/GCP trained pharmacists accountable for dispensing. Distribution is executed by trained premium couriers to patient homes wherever located in Australia, with end-to-end project management from dispensing through to administration. The company describes itself as a supply-chain service rather than a software platform; no API, app, or AI/ML capability is disclosed.

CPL operates on a professional-services revenue model with quote-based pricing (not publicly disclosed) and a sales-led go-to-market using direct outreach, a website contact form, and organic LinkedIn and Twitter presence. The founder-CEO Rima Darwiche, a registered pharmacist with two decades of clinical research experience, leads the firm. The company is independently owned with no parent company, no disclosed funding rounds, and a single domestic operating geography, making it a small specialist contractor in a category with strong tailwinds from the global shift toward decentralized trials.

Central Pharmacy Logistics Australia firmographics

Firmographics
Name
Central Pharmacy Logistics Australia
Legal name
Central Pharmacy Logistics Australia
Website
https://cplaustralia.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Central Pharmacy Logistics Australia (CPL) is a privately-held Australian clinical trial supply chain specialist that delivers and collects Investigational Products directly to and from patients' homes via its TGA-licensed Melbourne depot, serving pharmaceutical sponsors, CROs, and researchers running decentralized clinical trials across Australia.
Ownership category
akta.pro rank

Central Pharmacy Logistics Australia industry classification

Industry
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAGAMAC
Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLAIACAD
Pharmaceutical & Life Sciences Warehousing (GDP-Compliant)
Transportation & Logistics/Third-Party & Fourth-Party Logistics (3PL/4PL) / Contract Logistics/Warehousing Operations & Contract Storage (Dedicated/Shared)
SECONDARYTLAAAIAA
Clinical Specimen & Lab Diagnostics Courier (Blood, Tissue, Pathology)

Keywords

  • Clinical trial logistics
  • Direct-to-patient supply
  • Investigational product distribution
  • Decentralised clinical trials
  • Pharmacy depot services

Where Central Pharmacy Logistics Australia is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Central Pharmacy Logistics Australia business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Trial Supply Chain Services: Professional services for clinical drug trial distribution including storage, dispensing, and Direct-to-Patient delivery of Investigational Products (IP). Revenue is generated through service fees for managing the complete supply chain from depot to patient homes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Central Pharmacy Logistics Australia product offering

Product offering

Core offering

Central Pharmacy Logistics Australia provides Direct-to-Patient (DTP) delivery and Direct-From-Patient (DFP) collection of investigational products for clinical drug trials across Australia. Services are anchored at a TGA-licensed, GMP-compliant Melbourne depot operated by GMP/GCP-trained pharmacists, supported by premium couriers who deliver investigational products to and from patients' homes, enabling decentralised clinical trials.

Product overview

CPL offers a unified clinical trial supply chain platform centered on its Direct-to-Patient (DTP) and Direct-From-Patient (DFP) models. The DTP service enables investigational products to be delivered and administered at patients' homes, while the DFP service handles collection and return of products and samples. These services are supported by CPL's Melbourne-based depot, which provides temperature-controlled storage, GMP/GCP compliant dispensing by licensed pharmacists, and secure distribution through trained premium couriers.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Close to 30% of Australian population in rural/remote areas can participate in clinical trials

Companies that use Central Pharmacy Logistics Australia

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Central Pharmacy Logistics Australia technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Central Pharmacy Logistics Australia partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Central Pharmacy Logistics Australia competitors and assessment

Company assessment

Direct peers

  • Marken: Now part of UPS Healthcare, Marken is a global clinical trial logistics specialist offering Direct-to-Patient and Direct-From-Patient services, biologic specimen transport, and depot operations — a direct global counterpart to CPL's Australian DTP/DFP offering.
  • Biocair: Biocair specializes in temperature-controlled life sciences logistics including clinical trial IMP distribution, biological sample transport, and decentralized trial support — a close functional analogue to CPL's GMP depot and DTP model.
  • World Courier: Owned by Cencora, World Courier operates in over 50 countries with clinical trial supply chain, GMP-compliant storage, and DTP/DFP capabilities — overlapping directly with CPL's service portfolio at a materially larger scale.
  • Movianto: Movianto (part of Walden) operates as a specialty pharmaceutical logistics provider offering warehousing, distribution, and clinical trial supply across Europe, with capabilities that closely mirror CPL's TGA-licensed depot and DTP focus.
  • Yourway Transport: Yourway is a niche clinical trial logistics provider offering bio-pharmaceutical courier, clinical storage, and direct-to-patient services; functionally comparable to CPL though operating primarily in the Americas and Europe.

Emerging players

  • Cryoport Systems: Cryoport provides temperature-controlled supply chain solutions for life sciences, including clinical trial logistics for cell and gene therapies. Its emerging focus on complex biologic trial logistics overlaps with parts of CPL's GMP/GCP-monitored DTP offering.
  • Clinipace Worldwide (or dMed Global): Clinipace / dMed Global is a mid-sized CRO with embedded clinical supply and decentralized trial capabilities, offering overlapping support to sponsors running decentralized trials in Australia.

Broad incumbents

  • Almac Group: Almac provides end-to-end clinical trial supply, including clinical trial packaging, distribution, and clinical technologies. Its global clinical supply chain services sit alongside CPL's specialist depot/DTP offering but at significantly broader scale.
  • DHL Supply Chain (Life Sciences): DHL's Life Sciences division provides clinical trial logistics, cold-chain warehousing, and global distribution for pharmaceutical and biotech customers. As a broad incumbent, it competes with CPL on enterprise clinical trial contracts in Australia and the broader APAC region.
  • Fisher Clinical Services (Thermo Fisher Scientific): Part of Thermo Fisher, Fisher Clinical Services offers clinical trial packaging, labeling, storage, and global distribution including direct-to-patient logistics — a broader-portfolio incumbent comparable to CPL's clinical supply chain services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Central Pharmacy Logistics Australia social profiles

Digital presence

Central Pharmacy Logistics Australia compliance and trust

Trust signal

Compliance2 records

Central Pharmacy Logistics Australia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Central Pharmacy Logistics Australia leadership team

Management profile

Number of profiles

Central Pharmacy Logistics Australia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Central Pharmacy Logistics Australia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Central Pharmacy Logistics Australia

What does Central Pharmacy Logistics Australia do?

Central Pharmacy Logistics Australia provides Direct-to-Patient (DTP) delivery and Direct-From-Patient (DFP) collection of investigational products for clinical drug trials across Australia. Services are anchored at a TGA-licensed, GMP-compliant Melbourne depot operated by GMP/GCP-trained pharmacists, supported by premium couriers who deliver investigational products to and from patients' homes, enabling decentralised clinical trials.

Is Central Pharmacy Logistics Australia a public or private company?

Central Pharmacy Logistics Australia is a private company. It is currently operating.

When was Central Pharmacy Logistics Australia founded?

Central Pharmacy Logistics Australia was founded in 2019. It employs 11 to 50 people.

Where is Central Pharmacy Logistics Australia based?

Central Pharmacy Logistics Australia is headquartered in Melbourne, Australia, in the Oceania region.

How does Central Pharmacy Logistics Australia make money?

One revenue line is on record: clinical Trial Supply Chain Services.

Who are Central Pharmacy Logistics Australia's main competitors?

Direct peers on record are Marken, Biocair, World Courier, Movianto and Yourway Transport. Emerging players are Cryoport Systems and Clinipace Worldwide (or dMed Global). Broad incumbents are Almac Group, DHL Supply Chain (Life Sciences) and Fisher Clinical Services (Thermo Fisher Scientific).

Does Central Pharmacy Logistics Australia have an API?

No public API is recorded for Central Pharmacy Logistics Australia.

What industry is Central Pharmacy Logistics Australia in?

Its primary akta.pro industry code is HLAGAMAC, Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns), with a secondary code of TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales